Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

被引:211
作者
Ackerman, Margaret E. [1 ]
Mikhailova, Anastassia [2 ]
Brown, Eric P. [1 ]
Dowell, Karen G. [3 ]
Walker, Bruce D. [2 ,4 ]
Bailey-Kellogg, Chris [3 ]
Suscovich, Todd J. [2 ]
Alter, Galit [2 ]
机构
[1] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA
[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA
[3] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA
[4] Howard Hughes Med Inst, Chevy Chase, MD USA
关键词
DEPENDENT CELLULAR CYTOTOXICITY; STRUCTURED TREATMENT INTERRUPTION; EFFECTOR FUNCTION; PHAGOCYTIC-ACTIVITY; ANTIRETROVIRAL THERAPY; ANTIGEN-BINDING; HIGH-THROUGHPUT; VACCINE; VIRUS; NEUTRALIZATION;
D O I
10.1371/journal.ppat.1005315
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody-dependent cellular cytotoxicity (ADCC) that may contribute to viral containment, we profiled an array of extra-neutralizing antibody effector functions across HIV-infected populations with varying degrees of viral control to define the characteristics of antibodies associated with spontaneous control. While neither the overall magnitude of antibody titer nor individual effector functions were increased in ECs, a more functionally coordinated innate immune-recruiting response was observed. Specifically, ECs demonstrated polyfunctional humoral immune responses able to coordinately recruit ADCC, other NK functions, monocyte and neutrophil phagocytosis, and complement. This functionally coordinated response was associated with qualitatively superior IgG3/IgG1 responses, whereas HIV-specific IgG2/IgG4 responses, prevalent among viremic subjects, were associated with poorer overall antibody activity. Rather than linking viral control to any single activity, this study highlights the critical nature of functionally coordinated antibodies in HIV control and associates this polyfunctionality with preferential induction of potent antibody subclasses, supporting coordinated antibody activity as a goal in strategies directed at an HIV-1 functional cure.
引用
收藏
页数:14
相关论文
共 47 条
[1]
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type I infection [J].
Aasa-Chapman, MMI ;
Holuigue, S ;
Aubin, K ;
Wong, M ;
Jones, NA ;
Cornforth, D ;
Pellegrino, P ;
Newton, P ;
Williams, I ;
Borrow, P ;
Mcknight, A .
JOURNAL OF VIROLOGY, 2005, 79 (05) :2823-2830
[2]
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity [J].
Ackerman, Margaret E. ;
Crispin, Max ;
Yu, Xiaojie ;
Baruah, Kavitha ;
Boesch, Austin W. ;
Harvey, David J. ;
Dugast, Anne-Sophie ;
Heizen, Erin L. ;
Ercan, Altan ;
Choi, Ickwon ;
Streeck, Hendrik ;
Nigrovic, Peter A. ;
Bailey-Kellogg, Chris ;
Scanlan, Chris ;
Alter, Galit .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05) :2183-2192
[3]
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b [J].
Ackerman, Margaret E. ;
Dugast, Anne-Sophie ;
McAndrew, Elizabeth G. ;
Tsoukas, Stephen ;
Licht, Anna F. ;
Irvine, Darrell J. ;
Alter, Galit .
JOURNAL OF VIROLOGY, 2013, 87 (10) :5468-5476
[4]
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples [J].
Ackerman, Margaret E. ;
Moldt, Brian ;
Wyatt, Richard T. ;
Dugast, Anne-Sophie ;
McAndrew, Elizabeth ;
Tsoukas, Stephen ;
Jost, Stephanie ;
Berger, Christoph T. ;
Sciaranghella, Gaia ;
Liu, Qingquan ;
Irvine, Darrell J. ;
Burton, Dennis R. ;
Alter, Galit .
JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 366 (1-2) :8-19
[5]
AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428
[6]
Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating Anti-HIV-1 antibodies and prognostic predictors of HIV infection [J].
Ahmad, R ;
Sindhu, STAK ;
Toma, E ;
Morisset, R ;
Vincelette, J ;
Menezes, J ;
Ahmad, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) :227-233
[7]
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys [J].
Barouch, Dan H. ;
Stephenson, Kathryn E. ;
Borducchi, Erica N. ;
Smith, Kaitlin ;
Stanley, Kelly ;
McNally, Anna G. ;
Liu, Jinyan ;
Abbink, Peter ;
Maxfield, Lori F. ;
Seaman, Michael S. ;
Dugast, Anne-Sophie ;
Alter, Galit ;
Ferguson, Melissa ;
Li, Wenjun ;
Earl, Patricia L. ;
Moss, Bernard ;
Giorgi, Elena E. ;
Szinger, James J. ;
Eller, Leigh Anne ;
Billings, Erik A. ;
Rao, Mangala ;
Tovanabutra, Sodsai ;
Sanders-Buell, Eric ;
Weijtens, Mo ;
Pau, Maria G. ;
Schuitemaker, Hanneke ;
Robb, Merlin L. ;
Kim, Jerome H. ;
Korber, Bette T. ;
Michael, Nelson L. .
CELL, 2013, 155 (03) :531-539
[8]
Barouch DH, 2015, SCIENCE
[9]
Baum LL, 1996, J IMMUNOL, V157, P2168
[10]
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life [J].
Boesch, Austin W. ;
Alter, Galit ;
Ackerman, Margaret E. .
CURRENT OPINION IN HIV AND AIDS, 2015, 10 (03) :160-169